⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACRS News
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Receives Fast Track Designation for Modzatinib (ATI-2138) for Moderate to Severe Lichen Planus (LP)
globenewswire.com
ACRS
Aclaris Therapeutics Receives Fast Track Designation for Modzatinib (ATI-2138) for Moderate to Severe Lichen Planus (LP)
globenewswire.com
ACRS
Form 8-K
sec.gov
ACRS
Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update
globenewswire.com
ACRS
Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update
globenewswire.com
ACRS
UPMC Children's Hospital Foundation Celebrates Historic Community Investment in Children's Health
prnewswire.com
ACRS
Form 8-K
sec.gov
ACRS
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
globenewswire.com
ACRS
Huntress and Acrisure Announce New Cyber Insurance Program with No Deductible for Eligible Applicants
globenewswire.com
ACRS
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
globenewswire.com
ACRS